Sort
59,101 grants matching “hypertension”
Cellular Signaling and Kidney Function
$1,250,614Douglas C Eaton · Emory University · P01 · FY2008 · DK
Long-term sequelae of early life pesticide exposure in the CHAMACOS birth cohort
$1,250,450Brenda Eskenazi · University Of California Berkeley · UG3 · FY2017 · OD
Interactions Between Inflammation, Oxidant Stress and Cardiovascular Disease
$1,250,277David G Harrison · Vanderbilt University · P01 · FY2011 · HL
Clinical Trials Network: Long Island Regional Node
$1,250,000Edward V Nunes · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · U10 · FY2007 · DA
Delaware Valley Node of the Clinical Trials Network
$1,250,000George E Woody · University Of Pennsylvania · U10 · FY2007 · DA
Clinical and Translational Science Award
$1,250,000Reza Shaker · Medical College Of Wisconsin · UL1 · FY2021 · TR
LINKAGE CONSORTIUM FOR END-STAGE RENAL DISEASE
$1,250,000Case Western Reserve University · U01 · FY2000 · DK
Delaware Valley Node of the Clinical Trials Network
$1,250,000George E Woody · University Of Pennsylvania · U10 · FY2008 · DA
Mindfulness Influences on Self-Regulation: Mental and Physical Health Implications
$1,249,998Eric Loucks · Brown University · UH3 · FY2018 · AT
Data Coordinating Center for the Halt-Polycystic Kidney Disease Trials
$1,249,988Charity G Patterson (moore) · University Of Pittsburgh At Pittsburgh · U01 · FY2013 · DK
Microfabrication for Biomedical Research
$1,249,808Nicole Y Morgan · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2025 · EB
Safety, tolerability and efficacy of a novel sustained release analog of vasoactive intestinal peptide, PB1046, in patients with pulmonary arterial hypertension
$1,249,307John Lee · Phasebio Pharmaceuticals, Inc. · R44 · FY2019 · HL
San Diego EXPORT Comprehensive NCMHD Research Center
$1,249,184Sandra P Daley · University Of California, San Diego · P60 · FY2009 · MD
Impact of sex differences in immune function on shared risk for cardiometabolic disorder & Alzheimer's disease
$1,249,153Jill M Goldstein · Massachusetts General Hospital · R01 · FY2024 · AG
CREST-2 Statistical and Data Coordinating Center - SDCC
$1,249,046George Howard · University Of Alabama At Birmingham · U01 · FY2015 · NS
Comparative Toxicogenomics Database (CTD)
$1,248,836Carolyn J Mattingly · North Carolina State University Raleigh · U24 · FY2021 · ES
ADAPTATIONS TO HYPOXIA
$1,248,644University Of Colorado Denver · P01 · FY2000 · HL
Restoration of free radical homeostasis: novel therapy of septic shock
$1,248,631Andrew L Salzman · Radikal Therapeutics, Inc. · R44 · FY2016 · GM
Maternofetal Signaling and Lifelong Consequences\Overall
$1,248,020Kent L.r. Thornburg · Oregon Health & Science University · P01 · FY2008 · HD
Safety, tolerability and efficacy of a novel sustained release analog of vasoactive intestinal peptide, PB1046, in patients with pulmonary arterial hypertension
$1,247,966John Lee · Phasebio Pharmaceuticals, Inc. · R44 · FY2018 · HL
CHS Events Follow-up Study
$1,247,777Bruce M Psaty · University Of Washington · R01 · FY2010 · HL
Monetary incentives and intrinsic motivation to sustain hypertension control
$1,247,695Martin F Shapiro · University Of California Los Angeles · RC4 · FY2010 · AG
Integrative Omics as a Discovery Tool for Pulmonary Hypertension
$1,246,582Marlene Rabinovitch · Stanford University · R01 · FY2016 · HL
PERSEVERE-PEF: optimizing medical therapy saves lives in heart failure with preserved ejection fraction
$1,246,428Gabriela Voskerician · Optima Integrated Health, Inc. · R44 · FY2023 · HL
From GWAS loci to blood pressure genes, variants & mechanisms - Renewal
$1,245,814Aravinda Chakravarti · New York University School Of Medicine · R01 · FY2025 · HL